Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients

Thus far, studies investigating the differences in tumour characteristics between breast cancer in BRCA1-carriers and other patients, have focused on highly selected groups of patients, potentially limiting the conclusions that can be drawn. Previously, we had identified 10 patients with BRCA1 germline mutations in a hospital-based series of 642 breast cancer patients not selected for age or family history. The aim of this analysis is to investigate the clinical and pathological features of these BRCA1 associated carcinomas as compared to other breast cancers in this representative sample. Tumours from patients with BRCA1 germline mutations (n= 10) were compared to an age-matched sample of other patients (n= 50) from the same cohort. The following characteristics were considered: axillary nodal status and tumour size, histologic parameters (tumour type, histologic grade, mitotic rate, tubule formation, nuclear grade, CIS and lymphangio invasion) and expression of several proteins (oestrogen and progesterone receptors, cyclin D1, p53, HER2/neu, E-cadherin). In BRCA1associated tumours receptors for oestrogen and progesterone were expressed less frequently (respectively P= 0.001 and P= 0.002) than in controls, which is in line with findings from other studies. Other differences were also in accordance with findings from other studies, although not statistically significant. We conclude that the features of BRCA1 associated tumours detected in a hospital-based series of breast cancer patients not selected for family history of age at diagnosis are similar to tumours in cases selected for family history or age at diagnosis. © 2001 Cancer Research Campaign http://www.bjcancer.com

• Publication year

  2001

• Venue

  British Journal of Cancer

• Publication date

  2001-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1054/bjoc.2001.2103PMID 11720473PMCID 2375234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expert Commentary.

  2002cited by this paper
• Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer.

  2000cited by this paper
• Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients

  1999cited by this paper
• Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?

  1999cited by this paper
• Re: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

  1999cited by this paper
• Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations.

  1999cited by this paper
• Histological type and syncytial growth pattern affect E‐cadherin expression in a multifactorial analysis of a combined panel of sporadic and BRCA1‐associated breast cancers

  1999cited by this paper
• Hemophagocytic syndrome in five patients with Epstein–Barr virus negative B‐cell lymphoma

  1999influential reference
• Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study.

  1999influential reference
• More about: multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

  1999cited by this paper
• MORE ABOUT : MULTIFACTORIAL ANALYSIS OF DIFFERENCES BETWEEN SPORADIC BREAST CANCERS AND CANCERS INVOLVING BRCA1 AND BRCA2 MUTATIONS. AUTHORS' REPLY

  1999cited by this paper
• Pathobiologic characteristics of hereditary breast cancer.

  1998influential reference
• BRCA-associated breast cancer in young women.

  1998cited by this paper
• Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

  1998cited by this paper
• The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations

  1998influential reference
• Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

  1998influential reference
• Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.

  1997cited by this paper
• BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

  1997cited by this paper
• p53 mutations in BRCA1-associated familial breast cancer.

  1997cited by this paper
• Tumour biological features of BRCA1-induced breast and ovarian cancer.

  1997influential reference
• Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases

  1997cited by this paper
• Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women

  1997influential reference
• Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

  1996influential reference
• Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer.

  1996influential reference
• A simplified procedure for developing multiplex PCRs.

  1995cited by this paper
• Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sections

  1993cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.

  1988cited by this paper

• Germline BRCA testing in routine clinical practice: a single-center experience.

  2026cites this paper
• Characterization of the HER2 status in BRCA-mutated breast cancer: a single institutional series and systematic review with pooled analysis

  2022cites this paper
• Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study.

  2021influential citation
• Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China

  2019cites this paper
• Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines

  2017cites this paper
• BRCA1 protein expression and subcellular localization in primary breast cancer: Automated digital microscopy analysis of tissue microarrays

  2017cites this paper
• Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls

  2010cites this paper
• CCND1 and ZNF217 gene amplification is equally frequent in BRCA1 and BRCA2 associated and non-BRCA breast cancer.

  2010cites this paper
• Surgical Management of Hereditary Breast and Ovarian Cancer

  2010cites this paper
• Lymphovascular Invasion in BRCA Related Breast Cancer Compared to Sporadic Controls

  2009cites this paper
• Expression of BRCA1, HER-1

  2009cites this paper
• Genetic Markers in Breast Tumors with Hereditary Predisposition

  2008cites this paper
• Expression of BRCA1 protein in breast cancer and its prognostic significance.

  2008cites this paper
• PML protein expression in hereditary and sporadic breast cancer.

  2007cites this paper
• The Predominant Role of Surgery in the Prevention and New Trends in the Surgical Treatment of Women With BRCA1/2 Mutations

  2007cites this paper
• Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome

  2007cites this paper
• GENETICKÁ PREDISPOZICE KE VZNIKU MALIGNÍHO NÁDORU PRSU GENETIC SUSCEPTIBILITY TO BREAST CANCER

  2006cites this paper
• Breast cancer susceptibility testing: past, present and future

  2006cites this paper
• Expression of BRCA1, HER-1 (EGFR) and HER-2 in sporadic breast cancer and relationships to other clinicopathological prognostic features.

  2005cites this paper
• BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy.

  2005cites this paper
• Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant

  2004cites this paper
• Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

  2003cites this paper
• Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

  2003cites this paper
• p53 Inactivation is a Rare Event in Familial Breast Tumors Negative for BRCA1 and BRCA2 Mutations

  2003cites this paper
• HER‐2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry

  2002cites this paper